Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin

被引:90
作者
Alexandre, Kabamba B. [1 ]
Gray, Elin S. [1 ]
Lambson, Bronwen E. [1 ]
Moore, Penny L. [1 ]
Choge, Isaac A. [1 ]
Mlisana, Koleka [2 ]
Karim, Salim S. Abdool [2 ]
McMahon, James [3 ]
O'Keefe, Barry [3 ]
Chikwamba, Rachel [4 ]
Morris, Lynn [1 ]
机构
[1] Natl Inst Communicable Dis, ZA-2131 Johannesburg, South Africa
[2] Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, Durban, South Africa
[3] NCI, Ctr Canc Res, Mol Targets Lab, Frederick, MD 21701 USA
[4] Ctr Sci & Ind Res, Pretoria, South Africa
基金
美国国家卫生研究院; 新加坡国家研究基金会;
关键词
Griffithsin; Cyanovirin-N; Scytovirin; Lectins; HIV-1 subtype C; Microbicides; 2G12 monoclonal antibody; IMMUNODEFICIENCY-VIRUS TYPE-1; CYANOBACTERIUM SCYTONEMA-VARIUM; ENVELOPE GLYCOPROTEIN GP120; ANTIBODY NEUTRALIZATION; MONOCLONAL-ANTIBODIES; INACTIVATING PROTEIN; VAGINAL TRANSMISSION; ENV CLONES; 2G12; INFECTIONS;
D O I
10.1016/j.virol.2010.03.021
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学];
摘要
Griffithsin (GRFT), Cyanovirin-N (CV-N) and Scytovirin (SVN) are lectins that inhibit HIV-1 infection by binding to multiple mannose-rich glycans on the HIV-1 envelope glycoproteins (Env). Here we show that these lectins neutralize subtype C primary virus isolates in addition to Env-pseudotyped viruses obtained from plasma and cervical vaginal lavages. Among 15 subtype C pseudoviruses, the median IC50 values were 0.4, 1.8 and 20.1 nM for GRFT, CV-N and SVN, respectively, similar to what was found for subtype B and A. Analysis of Env sequences suggested that concomitant lack of glycans at positions 234 and 295 resulted in natural resistance to these compounds, which was confirmed by site-directed mutagenesis. Furthermore, the binding sites for these lectins overlapped that of the 2G12 monoclonal antibody epitope, which is generally absent on subtype C Env. This data support further research on these lectins as potential microbicides in the context of HIV-1 subtype C infection. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:187 / 196
页数:10
相关论文
共 52 条
[1]
Balzarini J, 2007, LANCET, V369, P787, DOI 10.1016/S0140-6736(07)60202-5
[2]
Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes [J].
Balzarini, Jan ;
Van Laethem, Kristel ;
Peumans, Willy J. ;
Van Damme, Els J. M. ;
Bolmstedt, Anders ;
Gago, Federico ;
Schols, Dominique .
JOURNAL OF VIROLOGY, 2006, 80 (17) :8411-8421
[3]
Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV [J].
Balzarini, O .
LANCET INFECTIOUS DISEASES, 2005, 5 (11) :726-731
[4]
The domain-swapped dimer of cyanovirin-N is in a metastable folded state: Reconciliation of X-ray and NMR structures [J].
Barrientos, LG ;
Louis, JM ;
Botos, I ;
Mori, T ;
Han, ZZ ;
O'Keefe, BR ;
Boyd, MR ;
Wlodawer, A ;
Gronenborn, AM .
STRUCTURE, 2002, 10 (05) :673-686
[5]
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies [J].
Binley, JA ;
Wrin, T ;
Korber, B ;
Zwick, MB ;
Wang, M ;
Chappey, C ;
Stiegler, G ;
Kunert, R ;
Zolla-Pazner, S ;
Katinger, H ;
Petropoulos, CJ ;
Burton, DR .
JOURNAL OF VIROLOGY, 2004, 78 (23) :13232-13252
[6]
A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium [J].
Bokesch, HR ;
O'Keefe, BR ;
McKee, TC ;
Pannell, LK ;
Patterson, GML ;
Gardella, RS ;
Sowder, RC ;
Turpin, J ;
Watson, K ;
Buckheit, RW ;
Boyd, MR .
BIOCHEMISTRY, 2003, 42 (09) :2578-2584
[7]
HIV-inhibitory natural products part 71 - Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner [J].
Bolmstedt, AJ ;
O'Keefe, BR ;
Shenoy, SR ;
Mcmahon, JB ;
Boyd, MR .
MOLECULAR PHARMACOLOGY, 2001, 59 (05) :949-954
[8]
Proteins that bind high-mannose sugars of the HIV envelope [J].
Botos, I ;
Wlodawer, A .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2005, 88 (02) :233-282
[9]
Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: Potential applications to microbicide development [J].
Boyd, MR ;
Gustafson, KR ;
McMahon, JB ;
Shoemaker, RH ;
OKeefe, BR ;
Mori, T ;
Gulakowski, RJ ;
Wu, L ;
Rivera, MI ;
Laurencot, CM ;
Currens, MJ ;
Cardellina, JH ;
Buckheit, RW ;
Nara, PL ;
Pannell, LK ;
Sowder, RC ;
Henderson, LE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) :1521-1530
[10]
Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1 [J].
Bures, R ;
Gaitan, A ;
Zhu, TF ;
Graziosi, C ;
McGrath, KM ;
Tartaglia, J ;
Caudrelier, P ;
EL Habib, R ;
Klein, M ;
Lazzarin, A ;
Stablein, DM ;
Deers, M ;
Corey, L ;
Greenberg, ML ;
Schwartz, DH ;
Montefiori, DC .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (18) :2019-2035